SIGA Technologies, Inc. Profile Avatar - Palmy Investing

SIGA Technologies, Inc.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox dise…

Drug Manufacturers - Specialty & Generic
US, New York [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

SIGA Technologies, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SIGA's Analysis
CIK: 1010086 CUSIP: 826917106 ISIN: US8269171067 LEI: - UEI: -
Secondary Listings
SIGA has no secondary listings inside our databases.